Milestone Pharmaceuticals Inc.

NASDAQ: MIST · Healthcare · Biotechnology

Canadian filerHQ Montreal, QCCIK 0001408443Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 47DQ —GM —SS 48

v0.1 · 35/100 weight · pillars only

↑ Piotroski F, market scale · ↓ return on equity, listing tenure

Methodology →

Revenue TTM

$1.8M

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$63.1M

Employees

Market cap

$113.4M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$63.1M-$63.1M2025

Operating income-$62.1M-$62.1M2025

Total assets$113.6M$113.6M2025

Liabilities$71.8M$71.8M2025

Equity$41.8M$41.8M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Milestone Pharmaceuticals Inc. earned -$63.1M in FY2025 net income.

Peers · Healthcare

Genelux Corporation33D Harbor Diversified, Inc.——Medexus Pharmaceuticals Inc.64C Grown Rogue International Inc.52D

Key facts

CEOJoseph G. Oliveto

SectorHealthcare

IndustryBiotechnology

HeadquartersMontreal, QC

ExchangeNASDAQ: MIST

Employees33

IPO date2019-05-09

Latest filings

8-K2026-06-15 10-Q2026-05-13 8-K2026-05-13 DEF 14A2026-04-30 8-K2026-03-20 10-K2026-03-20 8-K2026-01-26 8-K2026-01-13

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.